Researchers developed a holographic data storage approach that stores and retrieves information in three dimensions by ...

The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its ...

Physicists have directly tracked tiny points of darkness in laser light racing faster than light itself, without breaking Einstein’s rules. The new measurements show that these “dark points” in a ...

Nanotechnology therapeutics may reshape autoimmune disease care with targeted delivery and immune modulation. Read more.

A new programmable metasurface performs dynamic beamforming and radar cross-section reduction across five frequency bands in ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

Good morning, and welcome to Sarepta's preliminary data readout of its Phase I/II studies for DM1 and FSHD. As a reminder, today's program is being recorded. At this time, I'll turn the call over to ...

For patients with uncontrolled hypertension already on two or more medications, monthly injections of tonlamarsen (Kardigan) more effectively lowered plasma angiotensinogen (AGT) levels than a single ...

At this time, I would like to welcome everyone to the Karyopharm Therapeutics' call to discuss top line results from the Phase III SENTRY trial. There will be a question-and-answer session to follow.

Many households now support more than 50 wireless devices, making it challenging to ensure a consistent user experience.

Researchers at the University of Glasgow have built a tiny crystal chip that generates tunable terahertz waves and has kept ...